Meeting Brochure and registration form      SMDM Homepage

Sunday, October 21, 2007
P1-5

COST-EFFECTIVENESS OF HIV SCREENING IN PRISONS

Arielle Lasry, PhD1, Stephanie Sansom, PhD1, Ram K. Shrestha, PhD1, Krishna Jafa-Bhushan, MBBS1, Jennifer Taussig, MPH2, and Anne C. Spaulding, MD, MPH3. (1) Centers for Disease Control and Prevention, Atlanta, GA, (2) Georgia Division of Public Health, Atlanta, GA, (3) Emory University, Atlanta, GA

Purpose: From a societal perspective, we evaluate the cost effectiveness of multiple HIV screening strategies for male inmates, in a state prison system, to prevent HIV transmission.

Methods: HIV screening is an effective prevention intervention because awareness of one's positive serostatus reduces the probability of transmission. We consider HIV transmissions occurring among inmates, and in the community after HIV-infected inmates are released. Our key outcome is cost per case of HIV averted. Intraprison HIV transmission rates were drawn from a study of HIV transmission in a state prison system of 45,000 male inmates. Transmission rates in the community are derived from HIV incidence among high-risk groups. Testing costs were collected from a multi-site evaluation of HIV testing in jails. We consider three HIV screening strategies in prison: at entry, upon release and annually during incarceration. We evaluate all eight combinations of these strategies, including no screening. We use Markov cohort simulation to model the movement of prisoners to and from the community, and evaluate costs and outcomes over 25 years. Costs and outcomes are discounted at 3% annually.

Results: Screening upon release averts 1904 infections at a cost of $5700 each compared with no screening. This option is less expensive and more effective than screening at entry only, and screening annually only. An additional 37 infections can be averted at a cost of $297,143 each by screening at entry and release compared with screening upon release only.

Table 1: Costs and outcomes of HIV screening strategies among incarcerated males (US$2004)
Screening strategyTotal costTotal new HIV infections% new infections in communityIncremental CE ratio ($/ infection averted)
No screening$ 02,29296%n/a
Annual only $22,631,5681,12193%Dominated
Entry only$11,134,559 43585%Dominated
Release only$10,852,153 38874%$ 5,700
Release & annual$33,388,756 36379%Dominated
Entry & annual$33,658,446 35982%Dominated
Entry & release$21,846,461 35181%$ 297,143
Entry, release & annual$44,364,881 35082%$ 22,518,420

Conclusions/Implications: Screening prisoners upon their release is a cost-effective HIV prevention strategy. The majority of new infections occur in the community and screening upon release prevents the most infections in the community.